Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALFAMPRIDINE for Ill-defined disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where DALFAMPRIDINE was used for Ill-defined disorder.

Most Reported Side Effects for DALFAMPRIDINE

Side Effect Reports % Deaths Hosp.
Gait disturbance 8,780 15.6% 35 815
Drug ineffective 6,794 12.1% 20 341
Fall 5,554 9.9% 48 1,483
Therapy cessation 4,580 8.2% 27 594
Fatigue 3,778 6.7% 29 441
Balance disorder 3,753 6.7% 9 366
Multiple sclerosis relapse 3,322 5.9% 29 1,234
Condition aggravated 3,240 5.8% 25 409
Dizziness 2,959 5.3% 5 256
Urinary tract infection 2,757 4.9% 37 917
Insomnia 2,546 4.5% 12 165
Mobility decreased 2,512 4.5% 14 262
Asthenia 2,360 4.2% 36 551
Headache 2,241 4.0% 10 206
Multiple sclerosis 2,224 4.0% 89 537

Other Indications for DALFAMPRIDINE

Multiple sclerosis (28,787) Product used for unknown indication (17,590) Gait disturbance (13,663) Balance disorder (298) Relapsing-remitting multiple sclerosis (155) Muscular weakness (100) Asthenia (94) Secondary progressive multiple sclerosis (85) Fatigue (83) Mobility decreased (74)

Other Drugs Used for Ill-defined disorder

IBUPROFEN (707) ATORVASTATIN (570) DAPAGLIFLOZIN (556) SERTRALINE (437) AMLODIPINE (415) ROSUVASTATIN (361) OMEPRAZOLE (272) DOXYCYCLINE (254) PREGABALIN (248) LANSOPRAZOLE (227)

Related Pages

DALFAMPRIDINE Full Profile All Ill-defined disorder Drugs DALFAMPRIDINE Demographics DALFAMPRIDINE Timeline